Asset Details
Do you wish to reserve the book?
The Medical Necessity for Medicinal Cannabis : Prospective, Observational Study Evaluating the Treatment in Cancer Patients on Supportive or Palliative Care
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The Medical Necessity for Medicinal Cannabis : Prospective, Observational Study Evaluating the Treatment in Cancer Patients on Supportive or Palliative Care
Do you wish to request the book?
The Medical Necessity for Medicinal Cannabis : Prospective, Observational Study Evaluating the Treatment in Cancer Patients on Supportive or Palliative Care
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
The Medical Necessity for Medicinal Cannabis : Prospective, Observational Study Evaluating the Treatment in Cancer Patients on Supportive or Palliative Care
2013
Overview
Background. Cancer patients using cannabis report better influence from the plant extract than from synthetic products. However, almost all the research conducted to date has been performed with synthetic products. We followed patients with a medicinal cannabis license to evaluate the advantages and side effects of using cannabis by cancer patients. Methods. The study included two interviews based on questionnaires regarding symptoms and side effects, the first held on the day the license was issued and the second 6–8 weeks later. Cancer symptoms and cannabis side effects were documented on scales from 0 to 4 following the CTCAE. The distress thermometer was used also. Results. Of the 211 patients who had a first interview, only 131 had the second interview, 25 of whom stopped treatment after less than a week. All cancer or anticancer treatment-related symptoms showed significant improvement (P<0.001). No significant side effects except for memory lessening in patients with prolonged cannabis use (P=0.002) were noted. Conclusion. The positive effects of cannabis on various cancer-related symptoms are tempered by reliance on self-reporting for many of the variables. Although studies with a control group are missing, the improvement in symptoms should push the use of cannabis in palliative treatment of oncology patients.
Publisher
Hindawi Puplishing Corporation,Hindawi Publishing Corporation,John Wiley & Sons, Inc
Subject
